Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mono”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05153603
What this trial is testing

Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting

Who this might be right for
Ovarian Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Not applicableUnknownNCT02361853
What this trial is testing

The Role of Immature Myeloid Cells, Monocytes, Dentritic Cells and Neutrophils in Human Pregnancies as Markers for Mature Pregnancy and Spontaneous Labor

Who this might be right for
Parturition
Hillel Yaffe Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00651651
What this trial is testing

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5

Who this might be right for
Asthma
AstraZeneca 450
Testing effectiveness (Phase 2)Study completedNCT00543686
What this trial is testing

Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma

Who this might be right for
Asthma
Johann Wolfgang Goethe University Hospital 100
Early research (Phase 1)Study completedNCT02096718
What this trial is testing

Afatinib in Subjects With Kidney Dysfunction

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 30
Not applicableStudy completedNCT07480018
What this trial is testing

Berberine Supplementation, Sprint Interval Training, and Immune Function Study

Who this might be right for
BerberineSprint TrainingWellbeing+3 more
University of Northern Colorado 40
Testing effectiveness (Phase 2)Study completedNCT01351610
What this trial is testing

Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

Who this might be right for
Critical Limb IschemiaPeripheral Artery Disease
Apceth GmbH & Co. KG 25
Not applicableStudy completedNCT01577069
What this trial is testing

Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

Who this might be right for
Chronic Hepatitis C
Association HGE CHU Bordeaux Sud 73
Testing effectiveness (Phase 2)UnknownNCT06422156
What this trial is testing

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Peking University Third Hospital 73
Testing effectiveness (Phase 2)Study completedNCT02150824
What this trial is testing

Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 103
Not applicableStudy completedNCT03846908
What this trial is testing

Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)

Who this might be right for
Hypertriglyceridemia
Ludwig-Maximilians - University of Munich 13
Post-approval studies (Phase 4)Study completedNCT00002179
What this trial is testing

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 200
Not applicableStudy completedNCT05570643
What this trial is testing

The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Sepsis, Endotoxemia, Immunosuppression
Radboud University Medical Center 12
Not applicableUnknownNCT04262999
What this trial is testing

Bone Mineral Density and Periodontal Status in Patients on Antiepileptic Drug

Who this might be right for
Alveolar Bone Loss
Postgraduate Institute of Dental Sciences Rohtak 140
Not applicableUnknownNCT00173563
What this trial is testing

Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children

Who this might be right for
Healthy
National Taiwan University Hospital 10
Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Large-scale testing (Phase 3)Study completedNCT01958671
What this trial is testing

The Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 461
Testing effectiveness (Phase 2)Study completedNCT01625520
What this trial is testing

SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Federico II University 19
Not applicableEnrolling By InvitationNCT06800599
What this trial is testing

Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment

Who this might be right for
Genetic Predisposition to Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 7,000
Large-scale testing (Phase 3)Study completedNCT00687804
What this trial is testing

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study

Who this might be right for
Diabetic Macular Edema
Novartis 345
Next Page